Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-15

Clinical Trial Update: Augmenting Urinary Reflex Activity: Study 3 [NA]

View source ↗

Summary

An update on Amber Therapeutics' Study 3 evaluating augmentation of urinary reflex activity for urinary incontinence; the trial is currently active but not recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Amber Therapeutics Ltd | Conditions: Urinary Incontinence | NA | Status: ACTIVE_NOT_RECRUITING